Most Closely HLA-Matched CTLs for Relapsed Epstein Barr Virus(EBV)-Associated Diseases

Clinical trial NCT01447056 · COMPLETED

Trial details

NCT number: NCT01447056
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hodgkin Lymphoma Non-Hodgkin Lymphoma Lymphoproliferative Disorder Nasopharyngeal Carcinoma Leiomyosarcoma Severe Chronic Active EBV (SCAEBV)

Start date: 2012-02-01
Primary completion: 2015-03-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.